
SMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 01, 2024, titled "SMS Pharma receives EDQM certification to supply Ibuprofen in Europe.".
Filed with NSE ·

SMS Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 01, 2024, titled "SMS Pharma receives EDQM certification to supply Ibuprofen in Europe.".
6ix hasn’t read this filing yet.
SMS Pharmaceuticals Limited on 6ix
Follow SMS Pharmaceuticals into a list and get an email when it puts out news.
Follow SMS Pharmaceuticals